- Conditions
- HIV, Alcoholism
- Interventions
- Naltrexone, 50mg, once per day for 4 months, Sugar pill, 50mg, once per day for 4 months
- Drug · Other
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2012
- U.S. locations
- 3
- States / cities
- Washington D.C., District of Columbia • Jacksonville, Florida • Chicago, Illinois
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 457–480
of 3,377
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Nicotine Dependence
- Interventions
- GW468816, Placebo Comparator: Placebo
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years to 65 Years · Female only
- Enrollment
- 264 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 2
- States / cities
- Belmont, Massachusetts • Boston, Massachusetts
- Conditions
- Colorectal Cancer
- Interventions
- Usual Care FIT Screening Strategy, GeoMail FIT Screening Strategy
- Other
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 50 Years to 64 Years
- Enrollment
- 8,653 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Lupus
- Interventions
- BMS-931699, Placebo matching BMS-931699
- Drug
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 730 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 25
- States / cities
- Huntsville, Alabama • Fullerton, California • Long Beach, California + 22 more
- Conditions
- Shigella Infection
- Interventions
- Placebo, WRSs2, WRSs3
- Other · Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 89 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Iron Deficiency Anemia (IDA)
- Interventions
- Ferric Bepectate IV Injection, Ferric Carboxymaltose Injection [Ferinject], Ferric Carboxymaltose Injection [Injectafer®]
- Drug
- Lead sponsor
- AFT Pharmaceuticals, Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,366 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 7
- States / cities
- Coral Gables, Florida • Melbourne, Florida • The Villages, Florida + 4 more
- Conditions
- Healthy Volunteers
- Interventions
- GCC-4401C, Rivaroxaban, Placebo
- Drug
- Lead sponsor
- Green Cross Corporation
- Industry
- Eligibility
- 18 Years to 45 Years · Male only
- Enrollment
- 46 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Early Phase Clinical Unit _Los Angeles, California
- Conditions
- Alzheimer Disease
- Interventions
- cycloastragenol, placebo (for cycloastragenol)
- Dietary Supplement
- Lead sponsor
- Chippewa Valley Eye Clinic
- Other
- Eligibility
- 50 Years to 70 Years
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Eau Claire, Wisconsin
- Conditions
- Wounds
- Interventions
- Placebo gel, GLYC-101 gel (1.0 %)
- Drug
- Lead sponsor
- TR Therapeutics
- Industry
- Eligibility
- 25 Years to 65 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Beverly Hills, California
- Conditions
- Sarcoidosis; Antimycobacterial Therapy
- Interventions
- Levofloxacin, Ethambutol, Azithromycin, Rifampin, Placebo
- Drug
- Lead sponsor
- Vanderbilt University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2019
- U.S. locations
- 6
- States / cities
- Albany, New York • Cincinnati, Ohio • Cleveland, Ohio + 3 more
- Conditions
- Acute Otitis Media
- Interventions
- OP0201, Placebo, Amoxicillin-clavulanate
- Combination Product · Drug
- Lead sponsor
- Novus Therapeutics, Inc
- Industry
- Eligibility
- 6 Months to 24 Months
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Influenza Virus
- Interventions
- Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV), Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)
- Biological
- Lead sponsor
- Seqirus
- Industry
- Eligibility
- 6 Months to 71 Months
- Enrollment
- 10,644 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2016
- U.S. locations
- 91
- States / cities
- Chandler, Arizona • Harrisburg, Arkansas • Anaheim, California + 70 more
- Conditions
- Open-angle Glaucoma, Ocular Hypertension
- Interventions
- AGN-193408 SR, Lumigan, Sham Administration, Lumigan Vehicle
- Drug · Other
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2029
- U.S. locations
- 42
- States / cities
- Sun City, Arizona • Glendale, California • Inglewood, California + 38 more
- Conditions
- Suicide, Attempted, Suicide, Completed, Suicide Prevention, Mental Health Training, Rural Health, Veterans
- Interventions
- Virtual Reality Lethal Means Safety Training, 2D Video Training
- Behavioral
- Lead sponsor
- The University of Texas at Arlington
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Arlington, Texas
- Conditions
- Pregnancy Prevention
- Interventions
- Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo
- Drug · Other
- Lead sponsor
- InnovaGyn, Inc.
- Other
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Raleigh, North Carolina
- Conditions
- Recovery of Function (G11.427.698.620), Athletic Performance, Heart Rate Variability (HRV)
- Interventions
- Magnesium L-Threonate, Placebo
- Dietary Supplement · Other
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 18 Years to 35 Years
- Enrollment
- 109 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Hearing Loss, Well Aging
- Interventions
- Ear-worn prototype devices
- Device
- Lead sponsor
- 57GGardner
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Fremont, California
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral)
- Drug
- Lead sponsor
- Intarcia Therapeutics
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 245 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 96
- States / cities
- Fountain Hills, Arizona • Glendale, Arizona • Phoenix, Arizona + 81 more
- Conditions
- Chronic Inducible Urticaria
- Interventions
- barzolvolimab, Matching Placebo
- Biological · Drug
- Lead sponsor
- Celldex Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 196 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • Montgomery, Alabama • Paradise Valley, Arizona + 13 more
- Conditions
- Healthy Apheresis Donors, Mononuclear (MNC) Cell Donors
- Interventions
- Spectra Optia CMNC, COBE Spectra MNC, Granulocyte-colony stimulating factor (G-CSF)
- Device · Drug
- Lead sponsor
- Terumo BCT
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 23 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 2
- States / cities
- Cincinnati, Ohio • Memphis, Tennessee
- Conditions
- Stroke, Upper Limb Deficits
- Interventions
- Vagus Nerve Stimulation (VNS)
- Device
- Lead sponsor
- MicroTransponder Inc.
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2022
- U.S. locations
- 3
- States / cities
- Minneapolis, Minnesota • Dallas, Texas • Houston, Texas
- Conditions
- Pneumonia
- Interventions
- LRT55 Testing
- Device
- Lead sponsor
- Curetis GmbH
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,124 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Chicago, Illinois • Baltimore, Maryland + 6 more
- Conditions
- Schizophrenia
- Interventions
- repetitive transcranial magnetic stimulation (active), repetitive transcranial magnetic stimulation (sham)
- Device
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Catonsville, Maryland
- Conditions
- Allergic Conjunctivitis
- Interventions
- bepotastine besilate ophthalmic solution, placebo comparator ophthalmic solution
- Drug
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 245 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Irvine, California